Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
31-Aug-2018Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastomaSimon, T; Pinioti, S; Schellenberger, P; Rajeeve, V; Wendler, F, et al
22-Jun-2017MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (vol 9, e85935, 2014)Melaiu, O; Stebbing, J; Lombardo, Y; Bracci, E; Uehara, N, et al
14-Mar-2016Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer.Angelopoulos, N; Stebbing, J; Xu, Y; Giamas, G; Zhang, H
4-Aug-2015LMTK3 represses tumor suppressor-like genes through chromatin remodeling in breast cancerXu, Y; Zhang, H; Van, TMN; Angelopoulos, N; Nunes, J, et al
1-Jun-2015Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancerZhang, H; Angelopoulos, N; Xu, Y; Grothey, A; Nunes, J, et al
12-Nov-2013SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1Zhang, H; Xu, Y; Filipovic, A; Lit, LC; Koo, C-Y, et al
1-Sep-2015Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative ProteomicsStebbing, J; Zhang, H; Xu, Y; Grothey, A; Ajuh, P, et al
30-Mar-2016ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradationNunes, J; Zhang, H; Angelopoulos, N; Chhetri, J; Osipo, C, et al
15-Mar-2018LMTK3 confers chemo-resistance in breast cancerStebbing, J; Shah, K; Lit, LC; Gagliano, T; Ditsiou, A, et al